MedTrace Logo

MEDPass Trial: MedPass Versus Conventional Administration of Oral Nutritional Supplements

NCT03761680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2023-03-14

No results posted yet for this study

Summary

The aim of the randomized-controlled, single-center MEDPass trial is to assess the effects of MEDPass versus conventional administration of oral nutritional supplements (ONS) on energy and protein intake in medical and geriatric inpatients.

Conditions

  • Malnutrition

Interventions

DIETARY_SUPPLEMENT

MEDPass mode of administration

Allocation of 50 ml of ONS four times per day distributed with the medication rounds

DIETARY_SUPPLEMENT

Control Intervention

Patients receive ONS between meals or at their request as usual

Sponsors & Collaborators

  • Bern University of Applied Sciences

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Zeno Stanga, Prof.Dr.med. · Insel Gruppe AG, University Hospital Bern

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-22
Primary Completion
2021-12-30
Completion
2021-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03761680 on ClinicalTrials.gov